Cladribine inhibits secretion of pro-inflammatory cytokines and phagocytosis in human monocyte-derived M1 macrophages in-vitro

Galectin-3 (MAC-2) Controls Microglia Phenotype Whether Amoeboid and Phagocytic or Branched and Non-phagocytic by Regulating the Cytoskeleton

(2019) Fanny Reichert et al.   Frontiers in Cellular Neuroscience

Safety and efficacy of cladribine tablets in patients with relapsing–remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study

(2017) Gavin Giovannoni et al.   Multiple Sclerosis Journal

Cladribine to Treat Relapsing Forms of Multiple Sclerosis

(2017) Gavin Giovannoni   Neurotherapeutics

Safety and efficacy of cladribine tablets in patients with relapsing–remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study

(2017) Gavin Giovannoni et al.   Multiple Sclerosis Journal

2-Chlorodeoxyadenosine (cladribine) induces apoptosis in human monocyte-derived dendritic cells

(2013) V. Singh et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Cladribine exerts an immunomodulatory effect on human and murine dendritic cells

(2013) Stefan H.P. Kraus et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Cladribine interferes with IL-1β synaptic effects in experimental multiple sclerosis

(2013) Alessandra Musella et al.   JOURNAL OF NEUROIMMUNOLOGY

Impact of cladribine therapy on changes in circulating dendritic cell subsets, T cells and B cells in patients with multiple sclerosis

(2013) Krystyna Mitosek-Szewczyk et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Effects of 2-Chlorodeoxyadenosine (Cladribine) on Primary Rat Microglia

(2012) Vikramjeet Singh et al.   Journal of Neuroimmune Pharmacology

Cytotoxic purine nucleoside analogues bind to A1, A2A, and A3 adenosine receptors

(2012) Kyle Jensen et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Multiple sclerosis: Distribution of inflammatory cells in newly forming lesions

(2009) Andrew P. D. Henderson et al.   ANNALS OF NEUROLOGY

Adenosine: An endogenous modulator of innate immune system with therapeutic potential

(2009) Vijay Kumar et al.   EUROPEAN JOURNAL OF PHARMACOLOGY